Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Survival of patients with colorectal cancer (CRC) with low expression of homologous recombination proficient (HRP) genes.
Authors
Daniel Walden
Mayo Clinic Arizona, Phoenix, AZ;
Daniel Walden , Sachin Deshmukh , Felipe Batalini , Binbin Zheng-Lin , Sharon Wu , Joanne Xiu , Emil Lou , Daniel H. Ahn , Christina Wu , Sanjay Goel , Anthony Frank Shields , David Spetzler , Matthew James Oberley , Wolfgang Michael Korn , Tanios S. Bekaii-Saab
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 225)
DOI
10.1200/JCO.2023.41.4_suppl.225
Abstract #
225
Poster Bd #
M7
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Survival impact of homologous recombination deficiency in veterans with cholangiocarcinoma including mutual exclusivity with pathogenic KRAS and TP53.
First Author: Colin P. Bergstrom
Poster
2023 ASCO Annual Meeting
Chemotherapeutic sensitivity in colorectal cancer expressing low RNA of wild type homologous recombination genes.
First Author: Daniel Walden
Poster
2023 ASCO Annual Meeting
Comprehensive profiling of mutational signatures and machine learning and subtypes of homologous recombination deficiency.
First Author: Joonoh Lim
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan